![Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/57302335-10b7-4e3f-b402-4d25811a8f1f/ajt_1288_f3.gif)
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
![Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/cdt/17/9/07.gif)
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Laurent ARNAUD on X: "Interesting review 🔎 about #CD20 and anti-CD20 #treatments such as #rituximab or #obinutuzumab which are important drugs in the management of systemic #lupus 🐺 #openaccess 🔓 Link: https://t.co/pkzmhYIca4" /
![Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | Journal of Neurology Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | Journal of Neurology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00415-021-10744-x/MediaObjects/415_2021_10744_Fig2_HTML.png)
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | Journal of Neurology
![Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram](https://www.researchgate.net/publication/49731828/figure/fig1/AS:297465887641602@1447932802136/Potential-anti-CD20-mAb-effector-mechanisms-A-Fc-Fc-R-dependent-mechanisms-The-Fc.png)
Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram
![Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab](https://www.mdpi.com/brainsci/brainsci-10-00758/article_deploy/html/images/brainsci-10-00758-g001.png)